Nonhematological Neoplasms

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-09-09
Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of TAK-228 as Single Agent in Adult East Asian Participants With Advanced Nonhematological Malignancies [Phase 1]
Phase 1 trial evaluating TAK-228 as a single agent in adult East Asian participants with advanced nonhematological malignancies was terminat…